Dutasteride

January 4, 2016January 4, 2016

BPH Patients Treated with Dutasteride Have Less Bladder Obstruction

News

Benign prostatic hyperplasia (BPH) causes lower urinary tract symptoms (LUTS) due to bladder outlet obstruction (BOO) and overactive bladder (OAB). Treatment with dutasteride, a 5α-reductase inhibitor, improves LUTS but the ... Read more

November 9, 2015November 11, 2015

BPH Drug Seen to Reduce Post-Surgery Blood Loss in Patients

News

Researchers at the Hanyang University College of Medicine in Seoul have conducted a study indicating that treatment with dutasteride prior to transurethral resection of the prostate reduces bleeding and hospitalization ... Read more

October 23, 2015September 12, 2016

Possible BPH Therapy Seen in Using Curcumin as Dietary Supplement

News

Recent research revealed curcumin significantly decreases prostate weight and volume in animal models of benign prostatic hyperplasia (BPH). The study titled “Inhibitory effect of curcumin on testosterone induced benign prostatic hyperplasia rat ... Read more

October 13, 2015

Teva Announces Launch of Generic Avodart Capsules For BPH in the U.S.

News

Jerusalem based Teva Pharmaceutical Industries Ltd., has announced the U.S. launch of generic equivalents to GlaxoSmithKline’s Avodart (dutasteride) capsules, 0.5 mgs. Dutasteride is a medication used to treat symptoms of ... Read more

September 21, 2015September 21, 2015

Breckenridge Receives Tentative Approval For Generic Version Of Dutasteride BPH Drug

News

Pharmaceutical marketing, research and development company Breckenridge Pharmaceutical, Inc. announced it has received tentative Abbreviated New Drug Application (ANDA) approval of its generic Dutasteride Soft Gelatin Capsules 0.5mg product. Dutasteride is ... Read more